{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:00:05Z","timestamp":1793210405372,"version":"4.5.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Urine proteins can serve as viable biomarkers for diagnosing and monitoring various diseases. A comprehensive urine proteome database, generated from a variety of urine samples with different disease conditions, can serve as a reference resource for facilitating discovery of potential urine protein biomarkers. Herein, we present a urine proteome database generated from multiple datasets using 2D LC-MS\/MS proteome profiling of urine samples from healthy individuals (HI), renal transplant patients with acute rejection (AR) and stable graft (STA), patients with non-specific proteinuria (NS), and patients with prostate cancer (PC). A total of ~28,000 unique peptides spanning ~2,200 unique proteins were identified with a false discovery rate of &amp;lt;0.5% at the protein level. Over one third of the annotated proteins were plasma membrane proteins and another one third were extracellular proteins according to gene ontology analysis. Ingenuity Pathway Analysis of these proteins revealed 349 potential biomarkers in the literature-curated database. Forty-three percentage of all known cluster of differentiation (CD) proteins were identified in the various human urine samples. Interestingly, following comparisons with five recently published urine proteome profiling studies, which applied similar approaches, there are still ~400 proteins which are unique to this current study. These may represent potential disease-associated proteins. Among them, several proteins such as serpin B3, renin receptor, and periostin have been reported as pathological markers for renal failure and prostate cancer, respectively. Taken together, our data should provide valuable information for future discovery and validation studies of urine protein biomarkers for various diseases.<\/jats:p>","DOI":"10.3389\/fmed.2021.548212","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T02:13:03Z","timestamp":1618279983000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["A Comprehensive Urine Proteome Database Generated From Patients With Various Renal Conditions and Prostate Cancer"],"prefix":"10.3389","volume":"8","author":[{"given":"Adam C.","family":"Swensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingtang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie D.","family":"Nicora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tujin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara K.","family":"Sigdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minnie M.","family":"Sarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1152\/nips.01461.2003","article-title":"Why do we not all have proteinuria? An update of our current understanding of the glomerular barrier","volume":"19","author":"Haraldsson","year":"2004","journal-title":"News Physiol Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/pmic.200401012","article-title":"Renal and urinary proteomics: current applications and challenges","volume":"5","author":"Thongboonkerd","year":"2005","journal-title":"Proteomics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/bmj.287.6397.929","article-title":"Protein creatinine index and Albustix in assessment of proteinuria","volume":"287","author":"Shaw","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s004670050684","article-title":"A practical approach to proteinuria","volume":"13","author":"Bergstein","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrurol.2009.261","article-title":"Urine biomarkers in prostate cancer","volume":"7","author":"Ploussard","year":"2010","journal-title":"Nat Rev Urol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1158\/0008-5472.CAN-07-3224","article-title":"A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer","volume":"68","author":"Laxman","year":"2008","journal-title":"Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/sj.ki.5002715","article-title":"Urinary biomarkers in the early diagnosis of acute kidney injury","volume":"73","author":"Han","year":"2008","journal-title":"Kidney Int"},{"key":"B8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/MNH.0b013e3282f4e525","article-title":"Biomarkers in acute and chronic kidney disease","volume":"17","author":"Nickolas","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000102085","article-title":"Emerging biomarkers of acute kidney injury","volume":"156","author":"Devarajan","year":"2007","journal-title":"Contrib Nephrol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2006-7-9-r80","article-title":"The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins","volume":"7","author":"Adachi","year":"2006","journal-title":"Genome Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/prca.200900008","article-title":"Urine proteomics for profiling of human disease using high accuracy mass spectrometry","volume":"3","author":"Kentsis","year":"2009","journal-title":"Proteomics Clin Appl"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1021\/pr2003038","article-title":"A comprehensive map of the human urinary proteome","volume":"10","author":"Marimuthu","year":"2011","journal-title":"J Proteome Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/rcm.4441","article-title":"A comprehensive and non-prefractionation on the protein level approach for the human urinary proteome: touching phosphorylation in urine","volume":"24","author":"Li","year":"2010","journal-title":"Rapid Commun Mass Spectrom"},{"key":"B14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.dib.2014.08.006","article-title":"From hundreds to thousands: widening the normal human Urinome","volume":"1","author":"Santucci","year":"2014","journal-title":"Data Brief"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1038\/s41598-017-03226-6","article-title":"A comprehensive analysis and annotation of human normal urinary proteome","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/prca.200900124","article-title":"Shotgun proteomics identifies proteins specific for acute renal transplant rejection","volume":"4","author":"Sigdel","year":"2010","journal-title":"Proteomics Clin Appl"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.kint.2015.12.049","article-title":"Mining the human urine proteome for monitoring renal transplant injury","volume":"89","author":"Sigdel","year":"2016","journal-title":"Kidney Int"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/pmic.201000722","article-title":"Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells","volume":"11","author":"Wang","year":"2011","journal-title":"Proteomics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1021\/pr8001244","article-title":"Spectral probabilities and generating functions of tandem mass spectra: a strike against decoy databases","volume":"7","author":"Kim","year":"2008","journal-title":"J Proteome Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat Protoc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"W169","DOI":"10.1093\/nar\/gkm415","article-title":"DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists","volume":"35","author":"Huang","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1111\/j.1523-1755.2004.09220.x","article-title":"Why is proteinuria an ominous biomarker of progressive kidney disease?","volume":"92","author":"Zandi-Nejad","year":"2004","journal-title":"Kidney Int Suppl"},{"key":"B23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1021\/pr4010037","article-title":"State of the human proteome in 2013 as viewed through PeptideAtlas: comparing the kidney, urine, and plasma proteomes for the biology- and disease-driven human proteome project","volume":"13","author":"Farrah","year":"2014","journal-title":"J Proteome Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jprot.2014.07.021","article-title":"From hundreds to thousands: widening the normal human urinome (1)","volume":"112","author":"Santucci","year":"2015","journal-title":"J Proteomics."},{"key":"B25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/pmic.201100212","article-title":"Analysis of the urine proteome via a combination of multi-dimensional approaches","volume":"12","author":"Zerefos","year":"2012","journal-title":"Proteomics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/prca.201500102","article-title":"Biomarker discovery in mass spectrometry-based urinary proteomics","volume":"10","author":"Thomas","year":"2016","journal-title":"Proteomics Clin Appl"},{"key":"B27","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1021\/pr100576x","article-title":"Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology","volume":"9","author":"Chen","year":"2010","journal-title":"J Proteome Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1038\/s41598-020-60890-x","article-title":"Proteomic identification of early urinary-biomarkers of acute kidney injury in preterm infants","volume":"10","author":"Jung","year":"2020","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1242\/jcs.01222","article-title":"CD133, a novel marker for human prostatic epithelial stem cells","volume":"117","author":"Richardson","year":"2004","journal-title":"J Cell Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/sj.onc.1209327","article-title":"Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells","volume":"25","author":"Patrawala","year":"2006","journal-title":"Oncogene"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery","volume":"365","author":"Mishra","year":"2005","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","article-title":"Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury","volume":"62","author":"Han","year":"2002","journal-title":"Kidney Int"},{"key":"B33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1053\/j.ajkd.2003.10.040","article-title":"Urinary interleukin-18 is a marker of human acute tubular necrosis","volume":"43","author":"Parikh","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.5489\/cuaj.444","article-title":"Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng\/mL and 10 ng\/mL","volume":"1","author":"Bolduc","year":"2007","journal-title":"Can Urol Assoc J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.urology.2004.10.003","article-title":"Urinary\/serum prostate-specific antigen ratio: comparison with free\/total serum prostate-specific antigen ratio in improving prostate cancer detection","volume":"65","author":"Irani","year":"2005","journal-title":"Urology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.juro.2008.08.119","article-title":"Annexin A3 in urine: a highly specific noninvasive marker for prostate cancer early detection","volume":"181","author":"Schostak","year":"2009","journal-title":"J Urol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1021\/pr100835s","article-title":"Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome","volume":"10","author":"Nagaraj","year":"2011","journal-title":"J Proteome Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e2812","DOI":"10.1038\/cddis.2017.52","article-title":"The role of extracellular histone in organ injury","volume":"8","author":"Silk","year":"2017","journal-title":"Cell Death Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41391-019-0127-4","article-title":"Approaches to urinary detection of prostate cancer","volume":"22","author":"Eskra","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"270457","DOI":"10.1155\/2013\/270457","article-title":"Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study","volume":"2013","author":"Casadio","year":"2013","journal-title":"Biomed Res Int"},{"key":"B41","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1152\/ajpendo.00366.2002","article-title":"Aging and insulin secretion","volume":"284","author":"Chang","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/1471-2407-10-273","article-title":"Periostin is up-regulated in high grade and high stage prostate cancer","volume":"10","author":"Tischler","year":"2010","journal-title":"BMC Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12964-020-0531-3","article-title":"The (pro)renin receptor: a novel biomarker and potential therapeutic target for various cancers","volume":"18","author":"Wang","year":"2020","journal-title":"Cell Commun Signal"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.548212\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T02:13:06Z","timestamp":1618279986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.548212\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":43,"alternative-id":["10.3389\/fmed.2021.548212"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.548212","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.02.10.430660","asserted-by":"object"}]},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,13]]},"article-number":"548212"}}